icn pharmaceutical inc said did not view eastman kodak decision sell its pct share icn common stock having any effect status its drug ribavirin previously reported ongoing development drug antiviral field icn recently submitted data food and drug administration studies using its antiviral drug ribavirin for treating some aids related disorders statement icn also said sale will not effect its previously announced plans seek acquisition major pharmaceutical company icn also said planned sale will have effect its long term research partnership with kodak and kodak continued funding nucleic acid research institute two years ago kodak agreed invest mln dlrs over six years form and operate venture with icn explore new biomedical compounds acquired pct stake icn agreement icn said kodak today confirmed icn its continuing confidence progress joint project icn also said although were discussions today between icn and kodak regarding private sale shares icn decision has been made this matter reuter 